Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
This study has been completed.
Study NCT00504829   Information provided by Veloxis Pharmaceuticals

First Received on July 18, 2007.   Last Updated on April 11, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dyslipidemia
Additional conditions recognized in this trial
Dyslipidemias
More general conditions related to this trial
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
LCP-AtorFen
atorvastatin
fenofibrate
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Veloxis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services